| Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers KB Kuchenbaecker, JL Hopper, DR Barnes, KA Phillips, TM Mooij, ... Jama 317 (23), 2402-2416, 2017 | 2826 | 2017 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 422 | 2017 |
| Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ... Nature genetics 49 (12), 1767-1778, 2017 | 373 | 2017 |
| Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations TR Rebbeck, TM Friebel, E Friedman, U Hamann, D Huo, A Kwong, ... Human mutation 39 (5), 593-620, 2018 | 309 | 2018 |
| Tumor Mismatch Repair Immunohistochemistry and DNA MLH1 Methylation Testing of Patients With Endometrial Cancer Diagnosed at Age Younger Than 60 … DD Buchanan, YY Tan, MD Walsh, M Clendenning, AM Metcalf, ... Journal of Clinical Oncology 32 (2), 90-100, 2014 | 249 | 2014 |
| Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores J Lecarpentier, V Silvestri, KB Kuchenbaecker, D Barrowdale, J Dennis, ... Journal of Clinical Oncology 35 (20), 2240-2250, 2017 | 190 | 2017 |
| Gender differences in risk factors for coronary heart disease YY Tan, GCM Gast, YT van der Schouw Maturitas 65 (2), 149-160, 2010 | 172 | 2010 |
| RANKL/RANK control Brca1 mutation-driven mammary tumors V Sigl, K Owusu-Boaitey, PA Joshi, A Kavirayani, G Wirnsberger, ... Cell research 26 (7), 761-774, 2016 | 163 | 2016 |
| Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes L Fachal, H Aschard, J Beesley, DR Barnes, J Allen, S Kar, KA Pooley, ... Nature genetics 52 (1), 56-73, 2020 | 158 | 2020 |
| Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants DR Barnes, MA Rookus, L McGuffog, G Leslie, TM Mooij, J Dennis, ... Genetics in Medicine 22 (10), 1653-1666, 2020 | 108 | 2020 |
| Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers N Mavaddat, AC Antoniou, TM Mooij, MJ Hooning, ... Breast Cancer Research 22, 1-11, 2020 | 59 | 2020 |
| Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling SE Johnatty, YY Tan, DD Buchanan, M Bowman, RJ Walters, A Obermair, ... Gynecologic oncology 147 (2), 381-387, 2017 | 56 | 2017 |
| Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants: results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA) V Silvestri, G Leslie, DR Barnes, BA Agnarsson, K Aittomäki, E Alducci, ... JAMA oncology 6 (8), 1218-1230, 2020 | 55 | 2020 |
| Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study LH Schrijver, AC Antoniou, H Olsson, TM Mooij, MJ Roos-Blom, ... American Journal of Obstetrics and Gynecology 225 (1), 51. e1-51. e17, 2021 | 54 | 2021 |
| Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness VL Patel, EL Busch, TM Friebel, A Cronin, G Leslie, L McGuffog, J Adlard, ... Cancer research 80 (3), 624-638, 2020 | 52 | 2020 |
| Endometrial cancer risk and survival by tumor MMR status CM Nagle, TA O'mara, Y Tan, DD Buchanan, A Obermair, P Blomfield, ... Journal of gynecologic oncology 29 (3), 2018 | 48 | 2018 |
| Oral contraceptive use and breast cancer risk: retrospective and prospective analyses from a BRCA1 and BRCA2 mutation carrier cohort study LH Schrijver, H Olsson, KA Phillips, MB Terry, DE Goldgar, K Kast, ... JNCI cancer spectrum 2 (2), pky023, 2018 | 48 | 2018 |
| Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study F Qian, S Wang, J Mitchell, L McGuffog, D Barrowdale, G Leslie, ... JNCI: Journal of the National Cancer Institute 111 (4), 350-364, 2018 | 38 | 2018 |
| Polygenic risk modeling for prediction of epithelial ovarian cancer risk EO Dareng, JP Tyrer, DR Barnes, MR Jones, X Yang, KKH Aben, ... European Journal of Human Genetics 30 (3), 349-362, 2022 | 37 | 2022 |
| The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations MB Terry, Y Liao, K Kast, AC Antoniou, JA McDonald, TM Mooij, C Engel, ... JNCI cancer spectrum 2 (4), pky078, 2018 | 33 | 2018 |
